Orasis Pharmaceuticals
Luzi Andreas von Bidder is a board member at Orasis Pharmaceuticals. Luzi has previously served as the chairman of the board at Sequana Medical AG, Ferring Pharmaceuticals, and EyeSense AG. Luzi was also the CEO of Schweizerhall Management AG from 2003 to 2008.
Luzi Andreas von Bidder has a Master of Business Administration (MBA) in Marketing/Marketing Management, General from the University of St.Gallen.
This person is not in the org chart
This person is not in any offices
Orasis Pharmaceuticals
2 followers
Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.